
Claude finished the response
You're on the right track — you've typed treatment so far. Complete the filename box so it reads exactly:

treatment-definition/treatment_definition.Rmd
Just continue typing right after what's already there, so the full box shows treatment-definition/treatment_definition.Rmd (matching the folder name we planned — hyphens, not spaces, all lowercase, same style as pca-explained and main-analysis).

Then:

Click into the text area below.
Open the treatment_definition.Rmd file from my message above, select all, copy it, and paste it in.
Scroll down, click Commit changes..., keep "Commit directly to the main branch," click Commit changes.
Once that's in, repeat the same process for treatment-definition/README.md with the README content, and we'll check that it renders correctly.

shall we do the readme too?

Yes — let's do it now.

Step 1: Go back to your repo's main page (or into the treatment-definition folder if you're already there).
Step 2: Click Add file → Create new file.
Step 3: In the filename box, type: treatment-definition/README.md
(if you're already inside the treatment-definition folder, it may prefill that part — just make sure the full path reads treatment-definition/README.md)
Step 4: Click into the text area, open the README.md for treatment-definition from my earlier message, select all, copy, and paste it in.
Step 5: Scroll down, click Commit changes..., keep "Commit directly to the main branch," click Commit changes.

Once that's committed, open the treatment-definition folder on GitHub to confirm the README renders properly below the file list — then we'll move on to did-analysis/.

alright cool. so far so good and thanks. what is left?

Good progress — here's where things stand:

yelp-local-activity/
├── .gitignore
├── README.md                    ← still the original, not yet updated to link to subfolders
├── main-analysis/                ✅ done
├── pca-explained/                 ✅ done
└── treatment-definition/          ✅ done
Still to do:

did-analysis/ — the core method: Callaway & Sant'Anna staggered DiD + event study plots. This is the centerpiece, so I'll spend the most care on it.
robustness-checks/ — balance tables, sector-by-sector heterogeneity, alternate threshold specifications (60th/90th percentile versions), tying back to what we discussed in treatment-definition/.
(Optional, your call) ipw-dose-response/ — the doubly-robust/IPW dose-response piece, if you still want a 5th folder.
Update the root README.md — right now it still describes the project the old way (referencing the old filenames like Master_file_part1_fixed.Rmd). Once everything's split out, we should rewrite it as a short table of contents linking to each folder, so a visitor lands on a clear map of the whole repo instead of stale info.
Want me to build did-analysis/ next?

shall we fix the universal readme now or when all is done? otherwise, we can move to did-analysis

I'd wait until everything else is done. Here's why: the root README will need to link to every subfolder, and we still have did-analysis/ and robustness-checks/ (at minimum) to add — if we write it now, we'd just have to revise it again in a bit anyway. Better to do it once, cleanly, as the final step.

Let's move to did-analysis/ now. Let me pull the relevant code.


Synthesized DiD methodology and prepared comprehensive analysis framework
Synthesized DiD methodology and prepared comprehensive analysis framework
Good, I've got what I need — this is the heart of your thesis: Callaway & Sant'Anna's staggered DiD estimator, doubly-robust, with a "not-yet-treated" control group, plus the event-study dynamic version. Let me build this batch.


Created 2 files, ran a command, read a file
Created 2 files, ran a command, read a file
Here's the third batch: did-analysis/ — the centerpiece of your thesis.

did_analysis.Rmd — code-focused: att_gt() estimation, simple + dynamic aggregation, event-study plot, pre-trends check. Runs standalone on simulated data.
README.md — explains why Callaway & Sant'Anna over standard TWFE, what notyettreated and doubly-robust (dr) mean and why you chose them, why bootstrap/simultaneous bands, and how to read the event-study plot (including the pre-trends check).
Please verify before uploading — this one has more inferred "why" content than the last two, since I didn't ask you directly:

Did you choose notyettreated (over "nevertreated") deliberately because it uses more data / the never-treated group was small? Or for another reason?
Was doubly-robust (dr) a deliberate choice over just outcome-regression or just propensity-score methods, or the package default?
If either of those framings is off, tell me and I'll correct it — same as we did with the treatment thresholds.

Uploading, same process:

did-analysis/did_analysis.Rmd → paste, commit.
did-analysis/README.md → paste, commit.
Want to fix/confirm the two open questions first, or upload now and adjust after?


Did analysis
RMD 

Readme
Document · MD 

Want to be notified when Claude responds?





Claude is AI and can make mistakes. Please double-check responses.


Readme · MD
Staggered Difference-in-Differences (Callaway & Sant'Anna)
Part of the Yelp Reviews & Local Business Activity thesis project.

What's here
did_analysis.Rmd — a standalone, runnable version of the core DiD estimation, using the did package's att_gt()/aggte() functions. It runs on a small simulated panel with the same structure as the real data (see treatment-definition/ for how g, the first-treated year, is actually constructed, and pca-explained/ for PC1–PC4).

Why staggered DiD, not a standard two-way fixed effects regression
Counties don't all cross the "high review activity" threshold in the same year — some are treated in 2018, others not until 2021, and some never are. A standard two-way fixed effects (TWFE) regression with a single treatment dummy is known to produce biased estimates under this kind of staggered adoption, because it implicitly uses already-treated counties as part of the comparison group for later-treated ones. The Callaway & Sant'Anna (2021) estimator avoids this by estimating the treatment effect separately for each treatment-cohort/time-period combination, then aggregating those up cleanly.

Key design choices
control_group = "notyettreated" — at each point in time, the comparison group is counties that haven't been treated yet (rather than only counties that are never treated). This uses more of the available data and is more robust when the "never treated" group is small or unusual.

est_method = "dr" (doubly robust) — combines a regression-based outcome model with a propensity-score model for treatment timing. If either model is roughly right, the estimate stays consistent — it's a safeguard against getting the functional form of one model wrong.

xformla = ~ PC1 + PC2 + PC3 + PC4 + region_name — the same four PCA-derived demographic controls used throughout the project (see pca-explained/), plus region fixed effects, so group-time effects are estimated net of demographic composition and regional differences.

bstrap = TRUE, biters = 200, cband = TRUE — standard errors and confidence bands come from a multiplier bootstrap (200 iterations) rather than closed-form formulas, which is more reliable with a panel of this size and gives simultaneous confidence bands valid across the whole event-study path, not just pointwise.

From group-time effects to one result
att_gt() produces a separate estimate for every treatment-cohort × calendar-year combination — informative, but not a single headline number. Two aggregations are used:

type = "simple" — one overall average treatment effect on the treated, collapsing across cohorts and time.
type = "dynamic" — effects organized by event time (years since treatment, not calendar year), which is what the event-study plot shows. This is the more informative version, since it reveals how the effect evolves before and after treatment, not just its average size.
Reading the event-study plot
Two things to look for:

Pre-treatment estimates (event time < 0) close to zero — this is the empirical check for the parallel trends assumption the whole design relies on. If treated and not-yet-treated counties were already diverging before treatment, the design's core assumption is in trouble.
Post-treatment estimates (event time ≥ 0) — the actual effect of crossing the review-activity threshold, and whether it grows, shrinks, or stays flat as time since treatment passes.
Summary
Choice	Reason
Callaway & Sant'Anna over TWFE	Staggered adoption timing biases standard TWFE
notyettreated control group	Uses more data than a never-treated-only comparison
Doubly robust estimation	Robust to misspecifying either the outcome or propensity model
PCA controls + region FE	Nets out demographic composition and regional differences
Bootstrap, simultaneous bands	More reliable inference at this panel size
Dynamic (event-study) aggregation	Shows the full time path, and lets pre-trends be checked directly



